Mitomycin

• Efficacy of the use of neoadjuvant with/without hyperthermic intraperitoneal chemotherapy in the treatment of locally advanced colon cancer Pending
  2025-520471-29-00 Phase III 1 country Fundacion Para La Investigacion Biomedica De Cordoba
• A Phase 3 Single-arm Study of UGN-104 for the Treatment of LG-UTUC Recruiting
  2024-519343-15-00 Phase III 6 countries Urogen Pharma Ltd.
• Chemoablation or bladder resection with adjuvant chemotherapy in recurrent non-muscle invasive bladder cancer Recruiting
  2022-502221-18-00 Phase IV 4 countries Aarhus University
• Study to evaluate the efficacy and safety of supportive mitomycin C administered via electric current in the treatment of non-muscle invasiv… Recruiting
  2024-520006-19-00 Phase IV 1 country Presurgy S.L.
• CLINICAL TRIAL TO EVALUATE BLADDER INSTILLATION OF NEOADJUVANT CHEMOTHERAPY TO TRANSURETHRAL RESECTION OF THE BLADDER FOR THE PREVENTION OF … Recruiting
  2024-512683-53-00 Phase IV 1 country Hospital Universitario La Paz
• A Phase 3, Randomized, Open-label, Multicenter Study Evaluating the Efficacy and Safety of TAR-210 Erdafitinib Intravesical Delivery System … Recruiting
  2024-519493-39-00 Phase III 7 countries Janssen Cilag International
• Ezabenlimab (BI 754091) and DCFm (docetaxel, cisplatin and 5-fluorouracil) followed by chemoradiotherapy for the treatment of stage III anal… Recruiting
  2024-514083-31-00 Phase II 1 country Centre Hospitalier Regional Universitaire
• A study comparing TAR-210 versus single agent treatment instilled directly into the bladder in people with bladder cancer with FGFR gene alt… Recruiting
  2023-507684-19-00 Phase III 10 countries Janssen Cilag International
• Prospective randomised study of the impact of preoperative administration of mitomycin-C by electromotive drug administration (EMDA) in pat… Recruiting
  2024-510867-42-00 Phase IV 1 country Fundacion Para El Fomento De La Investigacion Sanitaria Y Biomedica De La Comuni…
• Multicentre Phase IV clinical trial to evaluate the efficacy of hyperthermic intraoperative chemotherapy (HIPEC) with Mitomycin-C after comp… Recruiting
  2024-512726-28-00 Phase IV 1 country Hospital Universitario De Fuenlabrada
• Intravesical instillation therapy with bacillus Calmette-Guérin (BCG) and sequential BCG and electromotive mitomycin-C (EMDA-MMC) in patient… Recruiting
  2024-516320-33-00 Phase III 1 country Turku University Hospital
• A phase 1b-2 study of mitomycin-C / capecitabine chemoradiotherapy combined with ipilumimab and nivolumab or nivolumab monotherapy as bladde… Ended
  2023-509460-19-00 Phase I/II 1 country Amsterdam UMC
• A Phase 3, Randomized, Open-label, Multi-center Study Evaluating the Efficacy and Safety of TAR-200 Versus Investigator’s Choice of Intraves… Ended
  2023-507685-10-00 Phase III 7 countries Janssen Cilag International
• PRODIGE 85 (FFCD 1804) – KANALRAD Prospective randomized phase III study evaluating induction chemotherapy (modified DCF 4 cycles) followed… Ended
  2023-505972-32-00 Phase III 1 country Fondation Franc.Cancerologie Digestive
• TACE-3: A two-arm multi-stage (TAMS) seamless phase II/III randomised trial of nivolumab in combination with TACE/TAE for patients with inte… Ended
  2024-513882-38-00 Phase II/III 1 country The Clatterbridge Cancer Centre NHS Foundation Trust
• A Phase 3 Single-Arm Study of UGN-102 for Treatment of LG IR NMIBC Ended
  2023-506680-34-00 Phase III 7 countries Urogen Pharma Ltd.
• Adjuvant instillations in intermediate risk NMIBC: A Study comparIng Gemcitabine and MitomYciN (SIGYN-trial) Ended
  2023-504945-30-00 Phase III 1 country Region Skane
• Phase III study of Pembrolizumab plus chemoradiation vs chemoradiation along for patients with muscle invasive bladder cancer Ended
  2023-503500-87-00 Phase III/IV 11 countries Merck Sharp & Dohme LLC
• SPARTANA : Spartalizumab, mDCF (docetaxel, cisplatin and 5-fluorouracil) and radiotherapy in patients with metastatic squamous cell anal car… Ended
  2024-516005-23-00 Phase II 1 country Centre Hospitalier Regional Universitaire
• A Randomized Phase 2 Study of Erdafitinib Versus Investigator Choice of Intravesical Chemotherapy in Subjects Who Received Bacillus Calmette… Ended
  2023-510306-40-00 Phase II 3 countries Janssen Cilag International
• The study evaluates the efficacy of the therapy of Mistletoe Extract in patients with superficial bladder cancer. There fore the Mistletoe E… Ended
  2023-503718-66-00 Phase III 1 country Abnoba GmbH

Showing 1–21 of 21 trials